December 27, 2016
Aspen Japan will roll out an authorized generic (AG) version of GlaxoSmithKline’s migraine drug Imigran (sumatriptan) on January 16, the company said on December 26. The Imigran AG will be the third AG product to be handled by the Japan...read more